Corporate Liaison and Ventures
Where Science Discoveries, Entrepreneurs, and Investors Converge
Get a sneak peek at the transformative biomedical research happening at Gladstone. Join the Industry Partnership Forum to talk to Gladstone scientists, learn more about research programs that are ready for translational opportunities, and discover how you can partner with our labs.
Presenting scientists will be available for a limited number of one-on-one meetings with both in-person and remote attendees.
Program and Speakers
| Time | Speaker |
|---|---|
| 10:00am | Welcome Ariel Brumbaugh, PhD, Biosciences Business Development Manager, Gladstone Institutes |
| 10:05am | Introduction to Gladstone Deepak Srivastava, MD, President, Gladstone Institutes |
| 10:10am | Small Molecule Nav1.1 Enhancers to Improve Network Functions in Alzheimer’s Disease and Epilepsy Jorge Palop, PhD, Associate Investigator, Gladstone Institutes Michael Pleiss, PhD, CNDAP Head of Medical Chemistry Stephen Freedman, PhD, Vice President, Corporate Liaison and Ventures, Gladstone Institutes |
| 10:35am | Sprint Synthesis: Accelerating Biotechnology through a Novel Enzymatic DNA/RNA Synthesis Platform Christina Palka, PhD, Visiting Scientist, Gladstone Institutes Seth Shipman, PhD, Associate Investigator, Gladstone Institutes |
| 11:00am | Break |
| 11:20am | Operant BioPharma: Dynamic Drug Discovery in Live Cellular Biology with Artificial Intelligence Drew Linsley, PhD, Assistant Professor of Research, Brown University Jeremy Linsley, PhD, CSO, Operant Biopharma Steve Finkbeiner, MD, PhD, Senior Investigator and Director, Center for Systems and Therapeutics, Gladstone Institutes |
| 11:45am | Function Bio: Accelerating Drug Discovery with Ultra-Deep CRISPR Scanning in Human Immune Cells Alex Marson, MD, PhD, Director, Gladstone-UCSF Institute of Genomic Immunology |
| 12:10pm | Lunch |
| 12:55pm | Synfini: Virtual and Physical, Closed-Loop Discovery with the Synfini Platform Peter Madrid, PhD, Head of Scientific Development, Synfini Nathan Collins, PhD, Head of Strategic Alliances and Development, Synfini Doug Donzelli, CEO, Synfini Isha Jain, Assistant Investigator, Gladstone Institutes |
| 1:20pm | ClpP Inhibitors for Obesity, Diabetes, and NAFLD Yadong Huang, MD, PhD, Senior Investigator, Gladstone Institutes |
| 1:45pm | CELLutions for Neural Repair Lana Zholudeva, PhD, Staff Research Scientist I, Gladstone Institutes Michael Lane, PhD, Associate Professor, Drexel University |
| 2:10pm | Break |
| 2:30pm | Blocking APOE Transcription as a Therapeutic Target for Alzheimer’s Disease Jason Watts MD, PhD, NIEHS Earl Stadtman Investigator Vivian Cheung MD, Professor, University of Michigan, Ann Arbor Robert Mahley, MD, PhD, Senior Investigator and President Emeritus, Gladstone Institutes Alecia Muth, MBA, Entrepreneur-in-Residence, Gladstone Institutes |
| 2:55pm | CRISPR Therapeutics for Dominant Neurological Disease Bruce Conklin, MD, Senior Investigator, Gladstone Institutes |
| 3:20pm | Closing Remarks Stephen Freedman, PhD, Vice President, Corporate Liaison and Ventures, Gladstone Institutes |
| 3:30pm | Networking Reception |
Register to attend either in-person or virtually.
Details
Dates
October 24, 2023Time
10:00am-5:00pm PDTLocation
Mahley Auditorium, 1650 Owens Street, San Francisco, CA 94158 & OnlineContact(s)
Diversity, Equity, and Inclusion
At Gladstone, we are committed to providing events and professional development activities that resonate with our community’s diverse members. Our goal is to develop creative programming that encompasses a wide variety of ideas and perspectives to inspire, educate, and engage with everyone within our walls.
We want to effect positive change through our events and activities by providing a platform for discussions on important topics related to increasing diversity and inclusiveness in the sciences.